Back to User profile » Dr Fu-An Wang
Paper published by Dr Fu-An Wang:
Original Research
Transarterial Chemoembolization Plus Camrelizumab and Rivoceranib versus Camrelizumab and Rivoceranib Alone for BCLC Stage C Hepatocellular Carcinoma
Zhou WJ, Huang JT, Lu X, Hu D, Hong X, Wang FA, Lv PH, Zhu XL
Journal of Hepatocellular Carcinoma 2024, 11:2515-2524
Published Date: 20 December 2024